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A new clinical evidence-based gene-environment interaction 
model of depression
In our current understanding of mood disorders, the role of genes is diverse including the 
mediation of the effects of provoking and protective factors. Different or partially overlap-
ping gene sets play a major role in the development of personality traits including also 
affective temperaments, in the mediation of the effects of environmental factors, and in 
the interaction of these elements in the development of depression. Certain genes are 
associated with personality traits and temperaments including e.g., neuroticism, impulsivity, 
openness, rumination and extroversion. Environmental factors consist of external (early and 
provoking life events, seasonal changes, social support etc.) and internal factors (hormones, 
biological rhythm generators, comorbid disorders etc). Some of these environmental factors, 
such as early life events and some prenatal events directly influence the development of 
personality traits and temperaments. In the NEWMOOD cohort polymorphisms of the genes 
of the serotonin transporter, 5-HT1A, 5-HT1B and 5-HT2A and endocannabinoid CB1 receptors, 
tryptophan hydroxylase, CREB1, BDNF and GIRK provide evidence for the involvement of these 
genes in the development of depression. Based on their role in this process they could be 
assigned to different gene sets. The role of certain genes, such as promoter polymorphisms 
of the serotonin transporter (5-HTTLPR) and CB1 receptor has been shown in more than one 
of the above factors. Furthermore, gene-gene interactions of these promoters associated 
with anxiety suggest the application of these polymorphisms in personalized medicine. 
In this review we introduce a new model including environmental factors, genes, trait and 
temperament markers based on human genetic studies. 
(Neuropsychopharmacol Hung 2012; 14(4): 213-220; doi: 10.5706/nph201212001)
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Nature aNd Nurture: the iNteractioN 
betweeN geNetic variatioN iN the sero-
toNiN traNsporter aNd eNviroNmeNtal 
iNflueNces, aNd its effect oN mood  
aNd mood disorders
Depression is a common mental disorder contribut-
ing to significant burden and is expected to be among 
the most frequent causes of morbidity by 2020 in the 
developed world (Swartz and Rollman 2003). Studies 
indicate that the contribution of genetic factors to 
the development of depression is 30-40% (Dick et al., 
2010) and there is an increasing number of studies 
trying to establish the substrate of this genetic com-
ponent, with a vast array of methodologies including 
candidate gene to whole genome association studies. 
Due to its well-known role in the regulation of mood 
and also other symptoms and features associated 
with depressive illnesses as well as anxiety, one ma-
jor target of research is the serotonergic system and 
especially the serotonin transporter protein respon-
sible for the reuptake of serotonin after release and 
being the target molecule of major antidepressants, 
and its gene SLC6A4. In humans, the s (short) al-
lele of the 5-HTTLPR polymorphism of the sero-
tonin transporter gene was found to be associated 
with anxiety-related traits (Lesch et al., 1996; Gonda 
et al., 2007) and neuroticism, which conveys increased 
attention and sensitivity to environmental adversities 
and experiencing neutral stimuli as negative, as well as 
less effective coping mechanisms in the face of stress 
therefore increasing risk for the development of de-
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pression (Gonda et al., 2009). Subsequently, in human 
studies a vast variation of methodological approaches, 
including various stressors, self-report questionnaire 
methods, imaging studies, stress hormone activation, 
and post mortem brain studies supported a similar 
association between the s allele and stress-induced 
reactivity (Caspi et al., 2010). S allele carriers were 
found to show increased and faster developing activa-
tion in the amygdala, which is known to play a role in 
modulating vegetative and behavioural responses to 
environmental stressors and fearful stimuli, and alter-
ation in the functional and microstructural connectiv-
ity of the amygdala and the medial prefrontal cortex 
was also reported in s allele carriers. 5-HTTLPR was 
also found to be associated with other possible affec-
tive disease precursor states or phenomena including 
subthreshold depression (Gonda et al., 2005) and 
affective temperaments (Gonda et al., 2006). In a land-
mark longitudinal study in 2003 Caspi et al. (Caspi 
et al., 2003) demonstrated the effect of the s allele of 
the 5-HTTLPR polymorphism in the development 
of depressive symptoms in the face of stressful life 
events, a finding which has been subsequently con-
firmed by the largest metaanalysis, which included 
54 studies on altogether 41 thousand subjects (Karg 
et al., 2011). While some of the earlier contradic-
tory results concerning the association between life 
events, 5-HTTLPR genotype, and depression were 
attributed to differences regarding the definition, as-
sessment, inclusion of, and differentiation between 
distinct types of stressors and life events, this latter 
study also indicated that childhood and adolescent 
maltreatment, recent life events, or serious medical 
conditions are all more likely to lead to depression 
in those carrying the s allele or the ss genotype of 
the serotonin transporter gene. In a study in a large 
Hungarian population sample we observed similar 
and strongly significant associations in ss subjects 
and a moderate significant association in sl subjects 
between threatening life events and mood symptoms 
as measured by the Zung Self-rating Depression Scale 
(Lazary et al., 2008; Lazary 2010). While severe life 
events on their own explained 2.4% of the variance 
in mood symptoms, this ratio nearly doubled to 4.2% 
upon including the interaction effect of 5-HTTLPR 
genotype, and rose to 5.9% when genotype data of 
other polymorphisms of the serotonin transporter 
gene were also included in the model clearly indicat-
ing that genetic variability and environmental influ-
ences interact in regulating mood (Lazary et al., 2008).
To support the universalness of the role of the s al-
lele in mediating the effect of environmental stressors, 
stress vulnerability has been found to be associated 
with the serotonin transporter gene and compromised 
serotonin transporter function not only in human 
studies but also in multiple nonhuman experiments 
including rodents and all investigated mammalian 
species as well (Kantor et al., 2000; Lesch et al., 2003; 
Caspi et al., 2010). An association between the s allele 
and stress hormone levels as a function of stressful 
environment were reported in rhesus macaques, while 
increased anxiety was observed in serotonin trans-
porter deficient rodent models (Lesch et al., 2003; 
Caspi et al., 2010).
the uNiversal role of the 5-httlpr iN 
mediatiNg reactivity to eNviroNmeNtal 
factors: the good aNd the bad side  
of the same coiN
Although the association between the 5-HTLPR s 
allele and increased susceptibility towards mood 
symptoms when encountering adverse environmen-
tal events seems to be obvious, it must be borne in 
mind that the frequency of the s allele and s allele 
carriers in the general population is relatively high 
in spite of the obvious disadvantages it contributes 
to, which provokes the question why this variant did 
not become extinct over evolution (Bagdy 2012). One 
possible answer is the fact that presence of the s allele 
increases susceptibility towards not only negative, 
but also positive environmental events, hindering or 
promoting adaptation. S allele carriers were found to 
perform better in several cognitive tasks and were also 
found to manifest increased social conformity, with 
similar results in nonhuman primates, and it has been 
postulated that s allele-related hyperactivity of cor-
ticolimbic structures may characterise both anxiety-
related traits and the better social and cognitive skills 
of s allele carriers leaving it up to given environmental 
conditions to determine if the outcome will be posi-
tive or negative (Homberg and Lesch 2011). In our 
previously quoted study we observed better mood 
and lower depression scores in ss carriers compared 
to ll subjects if persons only without any exposure 
to threatening life events were included, a finding 
also reported in some other international studies, 
shedding light on the possible adaptive qualities as-
sociated with this variant (Lazary et al., 2008; Bagdy 
2012). These results suggest that this gene conveys a 
general increased reactivity towards the environment 
thus strengthening adaptive capacities or plasticity 
which may be evolutionally valuable. This hypothesis 
is also supported by the fact that among primates, 
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humans and rhesus macaques could adapt best to 
diverse ecological challenges, and these are the two 
primate species carrying this polymorphism (Belsky 
et al., 2009).
our curreNt uNderstaNdiNg  
aNd past, preseNt aNd future models  
of depressioN
Understanding the complexity of and the complex 
interaction between environmental and genetic fac-
tors in the background of depression contributes to 
the evolution of a new model of depression. Previous 
models postulated that in the presence of inherited 
disposition, life events encountered during childhood 
or adolescence contribute to increased vulnerability 
for developing depression in the face of severe or 
stressful life events during adulthood. In accordance 
with this model, in the presence of the s allele there 
is an increased susceptibility towards the mood dete-
riorating effects of childhood or later severe stressful 
life events. Our studies, however, pinpoint impor-
tant pitfalls of this model, as our results indicate no 
association between seasonality (encompassing an 
increased susceptibility towards seasonal affective 
disorder) and the 5-HTTLPR s allele (Molnar et al., 
2010). Similarly, rumination, a trait-like cognitive 
style associated with risk of depression was found to 
be associated with an interaction of 2 genes (CREB1, 
KCNJ6) and separately with the gene of BDNF playing 
a role in the neural regulation of cognitive processes, 
but not with the 5-HTTLPR (Lazary et al., 2011). 
These examples indicate that everyday stressors are 
varied and manifold, including childhood maltreat-
ment and abuse, regular adversities including losses 
and health problems, but also hormonal changes or 
change of seasons, and each individual has a distinct 
vulnerability profile towards them, just as everyone 
has a different susceptibility towards protective factors 
and events as well. Thus, different genes may have 
distinct actions in the development of depression 
as shown in Figure 1. The sensitivity towards the 
individual and combined effects of these factors is 
determined by heritable factors, distinct combina-
tions of genetic variants, contributing towards the 
proposal of a new model for depression (Bagdy 2012).
In a new depression model (Figure 1), several other 
genes besides the serotonin transporter gene play a 
role in the emergence of depression, and these candi-
date genes include those playing a role in serotonergic 
neurotransmission (HTR1A, HTR1B, HTR2A, TPH1, 
TPH2), dopaminergic neurotransmission (DRD2, 
DRD4) (Varga et al., 2011), monoamine metabolism 
(MAOA, COMT), genes of different neuropeptides, 
trophic factors and their receptors (CRH, CRHR, 
BDNF), proteins playing a role in other transport and 
transmission processes (SLC1A1, SLC6A2, P2RX7, 
CREB1/CREM, KCNJ6, CACNA1, GLUR7), as well 
as the endocannabinoid 1 receptor (CNR1), as based 
on human data so far (Lazary et al., 2011). Some of 
these have been confirmed also in the NEWMOOD 
studies (Table 1). CNR1, the gene of the CB1 receptor 
has been found to be most strongly related to depres-
sion besides the 5HTTLPR in our studies, showing 
an association with trait anxiety and neuroticism as 
well. Furthermore, the CNR1 influences trait anxiety 
in interaction with the 5-HTTLPR, increasing the risk 
of high trait anxiety 5-fold in the combined presence 
of the GG variant of the rs2180619 polymorphism in 
the regulatory region of the CNR1, and the ss vari-
ant of the 5-HTTLPR (Lazary et al., 2009), due to a 
sustained extremely high serotonin concentration 
following activation of serotonergic neurons after 
stress, resulting partly from a low expression of CB1 
receptors exerting an inhibitory effect on serotonin 
release, and partly from a low expression of the se-
rotonin transporter removing serotonin from the 
synaptic cleft and thus terminating its effects. Similar 
observation was reported in fMRI studies where in-
creased amygdala activation was found in ss carriers 
also characterised by increased neuroticism. CNR1 
gene polymorphisms in interaction with life events 
are also associated with the development of depres-
sion (Juhasz et al., 2009). These results support that 
candidate genes most strongly associated with depres-
sion and anxiety are the serotonin transporter gene 
(SLC6A4) and the CB1 receptor gene (CNR1) (Lazary 
et al., 2011) (Table 1), and suggest that depression 
manifests on the ground of various genes mediating 
the effects of diverse environmental influences, as well 
as the interaction between these genes (Bagdy 2012).
These genes could be divided into seven groups 
or gene sets based on their role towards the devel-
opment of depression as shown in Figure 1. Some 
of these have a protective, others a risk type role. 
Different gene sets play a role in the development of 
personality, in the mediation of the effects of envi-
ronmental factors, and in the interaction of differ-
ent elements of personality with the environmental 
factors. Environmental factors consist of external 
and internal influences. Some of the early environ-
mental factors directly influence the development of 
the personality traits and temperaments. The role of 
certain genes, such as promoter polymorphisms of the 
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serotonin transporter (5-HTTLPR) and CB1 recep-
tor genes have been shown in more than one of the 
above factors. Some of the genes such as tryptophane 
hydroxylase 2 (see also Table 1) are included in one 
gene set. The role of certain genes, such as promoter 
polymorphisms of the serotonin transporter (5-HT-
TLPR) and CB1 receptor genes have been shown 
in more than one of the above factors, namely in 
gene sets 1, 2, 4 and 6. It is interesting to note that 
even without one gene set, different genes may have 
separate roles, and not all genes are involved in all 
functions, e.g., 5-HTTLPR has a significant effect in 
mediating the effects of certain provoking life events, 
but it has no significant role in seasonal depression 
(Figure 1).
the practical side of scieNce: utilisiNg 
our expaNdiNg KNowledge coNcerNiNg 
the role of the 5-httlpr iN cliNical worK 
Implementing psychopharmacogenetics  
in personalised medicine
Psychopharmacogenetics has important information 
for personalised medicine (Weizman et al., 2012), 
as genotyping can be used to identify individuals who 
are susceptible for depression and anxiety, and are 
thus also more susceptible towards the anxiogenic 
and depressogenic side effects of certain medications. 
Several currently available medications have such 
side effects including interferon alpha, interleukin-2, 
Figure 1  A new gene-environment model of the development of depression. The effect of a large number of protective (e.g., social sup-
port, openness, trust, acceptance) and risk (e.g., neuroticism, impulsivity, rumination, stress) inherited and environmental factors is medi-
ated by various, only partly known genetic variants. The roles of individual genes could be identified only by studying each environmental 
factor, personality trait and temperament parallel with genetic polymorphisms in a large population. Different gene sets (Gs) play a role 
in the development of personality, in the mediation of the effects of environmental factors, and in the interaction of different elements 
of personality with the environmental factors in the development of depression. Environmental factors consist of external and internal 
factors. Some of the early environmental factors directly influence the development of the personality traits and temperaments. Some of 
the genes such as tryptophane-hydroxylase-2 (see also Table 1) are included in one gene set. The role of certain genes, such as promoter 
polymorphisms of the serotonin transporter (5-HTTLPR) and CB1 receptor genes have been shown in more than one of the above factors, 
namely in gene sets 1, 2, 4 and 6. It is interesting to note that even within one gene set, different genes may have separate roles, e.g., 5-HT-
TLPR has a significant effect in mediating the effects of certain provoking life events, but it has no significant role in seasonal depression. 
Modified from (Bagdy 2012).
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gonadotropin releasing hormone agonists, meflo-
quin, certain hormonal contraceptives, propranolol, 
isotretinoin, montelukast, vareniclyne and oseltamivir 
(Lazary et al., 2011), and 2 studies already indicated 
an association between 5-HTTLPR genotype and psy-
chiatric side effects in case of interferon alpha treat-
ment. CB1 receptor agonists, including rimonabant, 
were considered one of the most promising classes 
of medications against obesity and related metabolic 
and cardiovascular problems, induced anxiety and 
depression as a side effect in about 20% of patients, 
and also increased risk of suicide, prompting with-
drawal of rimonabant from the market. According 
to a model of an interaction between CB1 receptors 
and the serotonergic system in the amygdala playing 
a role in the regulation of anxiety and depression, 
stress-induced serotonin release activates postsynap-
tic 5HT2C receptors thus increasing anxiety (Kantor 
et al., 2000; Bagdy et al., 2001), and also leads to Gq 
protein activation and thus increased synthesis of the 
endocannabinoid 2-AG (Turu et al., 2009), which, 
as a retrograde neurotransmitter, activates inhibitory 
presynaptic CB1 receptors inhibiting further release 
of serotonin (Lazary et al., 2011). This inhibitory 
feedback circuit is more active with higher extracel-
lular serotonin concentration characteristic of those 
carrying the ss genotype of the 5-HTTLPR and thus 
expressing less serotonin transporter proteins. CB1 
antagonists such as rimonabant interfere with this 
inhibitory feedback circle thus leading to depression 
and anxiety, therefore those polymorphisms located 
in promoter regions and thus influencing protein 
expression of the serotonin transporter and the CB1 
receptors will influence the anxiogenic and depres-
sogenic effects of CB1 antagonists (Lazary et al., 2011). 
Based on our knowledge concerning the genetic back-
ground of depression and anxiety, screening for CB1 
receptor gene (CNR1) and serotonin transporter gene 
(SLC6A4) variants and their combinations can be 
useful to identify those individuals in whom CB1 
antagonists can safely be used without psychiatric 
side effects (Lazary et al., 2011),
Applying 5-HTTLPR related results in the 
treatment and prevention of psychiatric disorders
Another consequence of the significant, but relatively 
weak association of the 5-HTTLPR s allele with de-
pressogenic actions of stress is that it cannot be used 
for direct screening for depression susceptibility, and 
we can also suppose that in the absence of multiple 
severe environmental events s allele carriers will not 
manifest more depressive symptomatology than those 
carrying other genotypes. However, in the presence 
of environmental adversities and stressful life events 
s allele carriers have an increased risk for bad mood, 
less effective adaptation, and in certain cases, depres-
sion. Furthermore, these same people, who are at an 
increased risk for depression, show worse therapeu-
tic response to the most frequently used antidepres-
Parameters associated with mood and effects of mood-
influencing medications Protein Gene
Depressogenic and anxiogenic effects of medications SERT, CB1 SLC6A4, CNR1
Neuroticism, trait anxiety SERT, CB1 SLC6A4, CNR1
Effects of stress and negative life events on mood and 
depression SERT, CB1 SLC6A4, CNR1
Coping with stress 5-HT1A, 5-HT1B HTR1A, HTR1B
Susceptibility towards seasonal changes, depression 5-HT2A HTR2A
Hopelessness TPH2 TPH2
Rumination CREB1, GIRK, BDNF CREB1, KCNJ6, BDNF
Impulsiveness 5-HT1A, COMT HTR1A, COMT
Table 1  Association between genetic variants, mood-related heritable traits and mediation of environmental factors. Genes playing a 
role in the background of personality traits and temperaments related to mood and depression based on large-scale general population 
Hungarian studies (Bagdy et al., 2001; Lazary et al., 2008; Gonda et al., 2009; Juhasz et al., 2009; Lazary et al., 2009; Lazary 2010; Molnar et 
al., 2010; Juhasz et al., 2011; Lazary et al., 2012; Pap et al., in press). Modified from (Bagdy 2012).
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sive agents, SSRIs, due to later onset and lower rates 
of response and remission, worse tolerability and 
more frequent side effects in s allele carriers (Laje 
et al., 2009), while antidepressants with a different 
mechanism of action (for example noradrenaline 
selective agents) as well as psychotherapy were found 
to be more effective in their case (Rundell et al., 2011). 
However, viewing possible risk and protective factors 
in constellation, screening for 5-HTTLPR genotype 
could be part of a functional model to understand the 
evolving etiopathology of depression and detect those 
who are at a relatively high risk for mood disorders, 
and it could also prove to be a useful tool guiding 
selection of appropriate treatment (Kirilly et al., 2012).
future perspectives
In case of most common illnesses, the role of he-
reditary factors is estimated to exceed 30%, however, 
even with our state-of-the art methods, we can map 
only a fraction of this variation to well-defined ge-
netic variants and base-sequence alterations. This 
has drawn our attention also to epigenetic effects 
not affecting base sequences, but playing a role in 
regulating protein synthesis, and being only par-
tially heritable but modifiable by environmental 
effects (Falus and Molnar 2010). Two main epige-
netic mechanisms can modify the function of genes: 
(1) acetylation or methylation of histones that control 
the availability of DNA for further processes, and 
(2) methylation of the DNA itself, which suppresses 
the transcriptional activity of the CpG rich regions 
of the genes. Because these epigenetic changes are 
partially heritable, or, with other words, allele-specific, 
genetic polymorphisms are associated with different 
probability and type of epigenetic changes after en-
vironmental events and, as a consequence, consider-
able variances in sensitivity to environmental factors. 
A good example is the catechol-O-methyltransferase 
(COMT) gene, in which the presence of the Val158 al-
lele in the rs4680 polymorphism creates a CpG site for 
methylation, which repressive effect can compensate 
the increased dopamine elimination in the prefrontal 
cortex in the high-activity Val allele carriers. However, 
life stressors decrease the methylation of this part of 
the gene, resulting in increased COMT activity and 
thus impaired working memory performance due 
to decreased dopamine availability in this important 
brain region (Ursini et al., 2011). Investigating the 
effect of COMT gene on depression we found that 
variations in the COMT gene are associated with 
depressive symptom scores in those who have not 
been depressed previously but not in those who have 
already suffered from depression possibly because 
epigenetic changes alter the gene function in patients 
(Pap et al., in press). Although epigenetic changes are 
highly dynamic during the adaptation to function and 
environment, these changes can persist and last for 
several years. This might explain why abuse in early 
childhood increases the risk of later depressive disor-
der. For example, maternal maltreatment of rats in the 
postnatal period elicited long-lasting methylation of 
the BDNF gene in the prefrontal cortex and these ani-
mals showed impaired maternal behaviour towards 
their offspring (Roth et al., 2009), and in line with 
this, the BDNF gene in a human population study 
was associated with increased risk of depression only 
in the presence of childhood maltreatment (Juhasz 
et al., 2011). However, the main feature of epigenetic 
signature is its tissue and cell specificity, meaning that 
different parts of the brain show different methylation 
and acetylation patterns thus limiting our ability to 
investigate it in vivo human brain (Houston et al., 
in press). Nevertheless, since we have no method yet 
to asses these directly in the living brain, in order to 
understand physiological and pathological central 
nervous functions and to predict medication effects 
and side effects, gathering in-depth knowledge con-
cerning genetic base sequence and the interaction of 
its effects with environmental factors is still a primary 
target of research (Bagdy 2012).
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Jelen ismereteink szerint a hangulatzavarok kialakulásának hátterében meghúzódó geneti-
kai faktorok szerepe összetett. A személyiségvonások és temperamentumok kialakulásában 
és a környezeti hatások közvetítésében – bár ezek részben átfedést mutatnak – különböző 
gének csoportjai vesznek részt, ráadásul némelyik védő, mások hajlamosító tényezőként. 
A személyiségvonások és temperamentumok között fel kell sorolnunk a neuroticizmust, 
a szorongást, az impulzivitást, a nyitottságot, az extroverziót, a ruminációt és egyéb kognitív 
faktorokat, melyek részben a stressztűrő képesség elemeit is alkotják. A környezeti faktorokat 
alapvetően külső és belső tényezőkre oszthatjuk, előbbiek közé például a korai és a provokáló 
életeseményeket, az évszakváltást, a szociális támogatottságot, utóbbiak közé a hormono-
kat, biológiai ritmusgenerátorokat és a komorbid betegségeket sorolhatjuk. A környezeti 
tényezők közül néhány, így például a korai életesemények, vagy az intrauterin történések 
a személyiségjegyek és temperamentumok kialakulását is befolyásolják. A NEWMOOD adat-
bázisban a szerotonin transzporter, az 5-HT1A, 5-HT1B, 5-HT2A és a CB1 endokannabinoid 
receptor, valamint a triptofán hidroxiláz, a CREB1, a BDNF, valamint a GIRK csatorna depresszió 
kialakulásában játszott szerepét igazoltuk. A fentiek közül például a szerotonin transzporter 
és a CB1 receptor gén promoter polimorfizmusai több ponton is befolyásolják a depresszió 
létrejöttét, ugyanakkor ezeknek a polimorfizmusoknak a gén-gén interakciós hatása a vonás-
szorongás és temperamentum kialakulásában is jelentős, így a személyre szabott orvoslásban 
is felhasználható. Összefoglaló közleményünk egy új depressziómodellt mutat be, melyben 
a gének, környezeti faktorok, személyiségvonások és temperamentumok humán genetikai 
vizsgálataink eredményei alapján illeszkednek.
Kulcsszavak: 5-HTTLPR, gén-környezet interakció, bizonyítékokon alapuló, személyre szabott 
terápia, depresszió, neuroticizmus, életesemények
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